Treatment efficacy of short-term IFN-2beta for chronic hepatitis

UMIN ID: C000000208

Registered date:13/09/2011

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: chronic hepatitis C
• Date of first enrollment: 2005/02/01
• Target sample size: 10
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Intron (Interferon alpha 2b)

Outcome(s)

• Primary Outcome: HCV-RNA
• Secondary Outcome: transaminase

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 70years-old
• Gender: Male and Female
• Exclude criteria: liver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe complication-especially poor hematopoiesis, renal, cardiac or respiratory function

Related Information

• Primary Sponsor: Gunma Liver Study Group
• Source(s) of Monetary Support: Gunma Liver Study Group